Christoph Grohmann

Drug discovery | Induced proximity | ADC technology

Germany

About

Experience

  • Principal Scientist at Red Ridge Bio
    Jul 2026 - Present · 1 mo

    ADC Technologies

  • Independent Consultant at Freelance
    Jan 2026 - Present · 7 mos

  • Senior Scientist, II at Firefly Biologics
    Apr 2023 - Dec 2025 · 2 yrs 9 mos

    Project lead for Degrader-Antibody Conjugates (DACs) for application in oncology

  • Scientist at Nurix Therapeutics
    May 2022 - Mar 2023 · 11 mos

    Medicinal chemistry lead, Induced proximity (targeted protein degradation) Synthesis and characterisation of small molecule protein degraders for oncology & immunology

  • Visiting Scientist at Merck
    Mar 2021 - Mar 2022 · 1 yr 1 mo

    Discovery Chemistry and Chemical Biology: Target identification for development of novel anti-cancer therapeutics Synthesis and characterisation of Antibody-Drug Conjugates for oncology